n
(pharmacology) An antiretroviral drug (trademark Ziagen) taken orally in the form of its sulfate (C₁₄H₁₈N₆O)₂·H₂SO₄ in combination with other antiretroviral drugs to treat HIV infections. It is a synthetic nucleoside analog that acts by inhibiting reverse transcriptase. It causes potentially serious hypersensitivity reactions in a small percentage of patients.
n
(pharmacology) A drug used to treat hepatitis B and herpes simplex virus infection.
n
An oral nucleotide-analogue reverse transcriptase inhibitor used to treat hepatitis B.
n
A group of drugs taken together to fight the AIDS virus.
n
(pharmacology) An antiviral agent.
n
(pharmacology) A nucleoside reverse-transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV.
n
(pharmacology) An antiretroviral drug of the protease inhibitor class that is used to treat HIV infected patients.
n
(pharmacology) A drug being developed to treat HIV infection.
n
(pharmacology) An experimental nucleoside reverse-transcriptase inhibitor against HIV.
n
(pharmacology) An experimental drug candidate for the treatment of hepatitis C.
n
(pharmacology) An antiretroviral drug of the protease inhibitor class that is administered orally in the form of its sulfate C₃₈H₅₂N₆O₇·H₂SO₄ in conjunction with other antiretroviral agents to treat HIV infected patients.
n
(pharmacology) A nonnucleoside reverse transcriptase inhibitor that has been studied for the treatment of HIV.
n
Alternative form of zidovudine [(pharmacology) A nucleoside analog reverse-transcriptase inhibitor C₁₀H₁₃N₅O₄, a type of antiretroviral drug that inhibits replication of some retroviruses (such as HIV) and was first approved for the treatment of AIDS.]
n
A drug used to treat hepatitis infection
n
(medicine) An acyclic nucleotide phosphonate used to treat hepatitis B infection
n
(pharmacology) An anti-HIV drug derived from a betulinic acid-like compound.
n
A particular antiviral drug
n
(pharmacology) A protease inhibitor being studied as a treatment for hepatitis C.
n
(pharmacology) A protease inhibitor proposed for the treatment of HIV but discontinued in 2006.
n
(pharmacology) An antiviral drug used in the treatment of herpes zoster.
n
A tertiary aliphatic amine with antihypertensive effects.
n
(pharmacology) An integrase inhibitor under investigation for the treatment of HIV infection.
n
(pharmacology) An experimental drug candidate for the treatment of HIV infection.
n
(pharmacology) An antiviral drug C₈H₁₄N₃O₆P·2H₂O (trademark Vistide) administered intravenously for the treatment of cytomegalovirus retinitis in patients with AIDS.
n
(pharmacology) A drug used in the treatment of hepatitis C.
n
(medicine) A reverse transcriptase inhibitor used in the treatment of HIV
n
(pharmacology) An antiviral drug for the treatment of hepatitis B.
n
(pharmacology) A drug used in treating HIV.
n
(pharmacology) A drug for the treatment of hepatitis C.
n
(pharmacology) A particular macrocyclic peptidomimetic inhibitor of a protease.
n
(pharmacology) An antiretroviral drug 4-{[4-(mesitylamino)-2-pyrimidinyl]amino}benzonitrile used to prevent HIV infection in women.
n
(pharmacology) An antiretroviral drug of the protease inhibitor class that is used in to treat HIV infected patients.
n
(pharmacology) An antiviral drug for the treatment of hepatitis C virus infection.
n
(pharmacology) A drug (derived from isoquinoline) used in the treatment of hypertension
n
(pharmacology) A nonnucleoside reverse-transcriptase inhibitor used to treat HIV.
n
(pharmacology) An experimental drug for the treatment of hepatitis C.
n
(pharmacology) A failed experimental drug for the treatment of HIV.
n
(pharmacology) A reverse transcriptase inhibitor drug C₁₀H₁₂N₄O₃ which inhibits the replication of HIV and is used in the treatment of AIDS, especially in combination with zidovudine. It is a synthetic analog of a purine nucleoside.
n
Alternative form of doravirine [(pharmacology) A reverse transcriptase inhibitor used to treat HIV.]
n
(pharmacology) A reverse transcriptase inhibitor used to treat HIV.
n
(pharmacology) A nonnucleoside reverse-transcriptase inhibitor C₁₄H₉ClF₃NO₂ that is administered orally with other antiretroviral agents in the treatment of type-1 HIV infection.
n
(pharmacology) Abbreviation of efavirenz. [(pharmacology) A nonnucleoside reverse-transcriptase inhibitor C₁₄H₉ClF₃NO₂ that is administered orally with other antiretroviral agents in the treatment of type-1 HIV infection.]
n
(pharmacology) An experimental drug for the treatment of hepatitis C.
n
(pharmacology) An integrase inhibitor used to treat HIV infection.
n
(pharmacology) An experimental nucleoside reverse-transcriptase inhibitor for the treatment of HIV.
n
(pharmacology) A synthetic nucleoside reverse-transcriptase inhibitor C₈H₁₀FN₃O₃S (trademarks Atripla, Complera, Emtriva, Stribild, Truvada) administered orally typically in conjunction with other antiretroviral agents for the treatment of HIV infection.
n
(pharmacology) An HIV fusion inhibitor, the first of a novel class of antiretroviral drugs.
n
(pharmacology) An oral antiviral drug used in the treatment of hepatitis B infection.
n
(pharmacology) Abbreviation of etravirine. [(pharmacology) A particular drug used for the treatment of HIV.]
n
Alternative form of etravirine [(pharmacology) A particular drug used for the treatment of HIV.]
n
(pharmacology) A particular drug used for the treatment of HIV.
n
(pharmacology) An experimental drug for the treatment of hepatitis C.
n
(pharmacology) An antiviral drug with activity against many RNA viruses.
n
(pharmacology) An antiviral drug.
n
(pharmacology) An antiviral drug used in the treatment of cytomegalovirus retinitis in immunocompromised patients, including those with AIDS.
n
(pharmacology) An antiretroviral prodrug of the protease inhibitor amprenavir. It is used to treat HIV infected patients.
n
(pharmacology) The salt form of the protease inhibitor drug fosamprenavir used in the treatment of HIV infected patients.
n
(pharmacology) An experimental HIV entry inhibitor that is a prodrug of temsavir.
n
An experimental drug for the treatment of hepatocellular carcinoma
n
(medicine) An antiviral drug used to treat cytomegalovirus infections
n
(pharmacology) A protease inhibitor used to treat hepatitis C.
n
(pharmacology) An experimental drug for the treatment of hepatitis C.
n
(pharmacology) Abbreviation of indinavir. [(pharmacology) An antiretroviral drug C₃₆H₄₇N₅O₄ of the protease inhibitor class that is used in the form of its sulfate in combination with antiretroviral drugs (such as zidovudine) to treat HIV infected patients.]
n
(pharmacology) An antiretroviral drug C₃₆H₄₇N₅O₄ of the protease inhibitor class that is used in the form of its sulfate in combination with antiretroviral drugs (such as zidovudine) to treat HIV infected patients.
n
(medicine) An antiviral drug that prevents the multiplication of HIV cells
n
An experimental inhibitor of nucleoside reverse transcriptase translocation
n
Trade name of molnupiravir
n
(pharmacology) A nucleoside analog reverse-transcriptase inhibitor, 2′,3′-dideoxy-3′-thiacytidine (C₈H₁₁N₃O₃S) that is taken orally in the treatment of HIV and chronic hepatitis B.
n
(pharmacology) A neuraminidase inhibitor used to treat influenza.
n
(pharmacology) A protease inhibitor.
n
(pharmacology) A particular drug for the treatment of hepatitis C.
n
(pharmacology) An antiviral drug.
n
(pharmacology) An antiviral drug.
n
A particular farnesyl-OH-transferase inhibitor.
n
(pharmacology) An antiretroviral drug C₃₇H₄₈N₄O₅ of the protease inhibitor class that is taken orally usually in conjunction with other retroviral agents (such as ritonavir) to treat HIV infected patients.
n
(pharmacology) A specific drug used in the treatment of HIV to inhibit viral entry into cells.
n
(pharmacology) An experimental antiviral drug for the prevention and treatment of human cytomegalovirus disease in transplant patients.
n
(pharmacology) A locked nucleic acid-based antisense oligonucleotide with potential medical applications.
n
(pharmacology) An antiviral drug developed to treat COVID-19, the first to obtain regulatory approval in the Western World, from the MHRA in the United Kingdom.
n
(medicine) An antiviral drug for the treatment of a hepatitis
n
(pharmacology) An antiretroviral drug (trademark Viracept) of the protease inhibitor class that is used in the form of its mesilate C₃₂H₄₅N₃O₄S·CH₄O₃S to treat HIV infected patients.
n
(pharmacology) The salt form of the protease inhibitor drug nelfinavir used in the treatment of HIV infected patients.
n
(pharmacology) An antiretroviral drug C₁₅H₁₄N₄O structurally related to the benzodiazepines that inhibits reverse transcriptase and is administered orally in combination with at least one other antiretroviral to treat HIV-1 infection.
n
(pharmacology) Abbreviation of nelfinavir. [(pharmacology) An antiretroviral drug (trademark Viracept) of the protease inhibitor class that is used in the form of its mesilate C₃₂H₄₅N₃O₄S·CH₄O₃S to treat HIV infected patients.]
n
(pharmacology) An antiviral drug developed to treat COVID-19, the second to obtain regulatory approval in the Western World, from the FDA in the United States of America.
n
An investigational drug for the treatment of spinal muscular atrophy.
n
(pharmacology) Abbreviation of nevirapine. [(pharmacology) An antiretroviral drug C₁₅H₁₄N₄O structurally related to the benzodiazepines that inhibits reverse transcriptase and is administered orally in combination with at least one other antiretroviral to treat HIV-1 infection.]
n
(pharmacology) A particular antiviral drug for the treatment of hepatitis C virus.
n
A drug used to treat non-small-cell lung carcinomas with a specific mutation.
n
(pharmacology) A protease inhibitor.
n
(pharmacology) An acylsulfonamide inhibitor of the NS3-4A serine protease, under investigation for the treatment of hepatitis C.
n
(pharmacology) A neuraminidase inhibitor being developed as an antiviral drug to treat influenza.
n
(pharmacology) An antiviral drug, used with glecaprevir to treat hepatitis C.
n
(pharmacology) A particular antiviral drug.
n
(pharmacology, virology) A class of drugs used to treat or prevent infection by viruses such as HIV and hepatitis C.
n
(pharmacology) An antiretroviral drug, an integrase inhibitor, used to treat HIV infection.
n
(pharmacology) A novel antiviral drug with activity against a wide range of single-stranded RNA viruses.
n
(pharmacology) A synthetic analog of guanosine C₈H₁₂N₄O₅ that inhibits viral nucleic acid synthesis and is used as a broad-spectrum antiviral drug especially in the treatment of respiratory syncytial virus infection and chronic hepatitis C.
n
(pharmacology) A drug used to treat HIV infection.
n
(pharmacology) A synthetic antiviral drug that is chemically related to amantadine and is administered orally in the form of its hydrochloride C₁₂H₂₁N·HCl in the prevention and treatment of influenza A; 1-(1-adamantyl)ethanamine.
n
(pharmacology) An antiretroviral drug C₃₇H₄₈N₆O₅S₂ of the protease inhibitor class that is administered orally to treat HIV-infected and AIDS patients.
n
(pharmacology) Abbreviation of ritonavir. [(pharmacology) An antiretroviral drug C₃₇H₄₈N₆O₅S₂ of the protease inhibitor class that is administered orally to treat HIV-infected and AIDS patients.]
n
(pharmacology) A particular synthetic protease inhibitor used as an antiviral drug.
n
(pharmacology) An antiretroviral drug C₃₈H₅₀N₆O₅ of the protease inhibitor class that is used in the form of its methylated sulfonic salt especially in combination with other antiretroviral agents to treat HIV infected patients.
n
(pharmacology) An experimental drug for the treatment of hepatitis C.
n
A drug for the treatment of hepatitis C.
n
A drug that is an inhibitor of respiratory syncytial virus replication
n
(pharmacology) A nucleotide analog used in combination with other drugs for the treatment of hepatitis C.
n
(pharmacology) A thymine analogue antiviral drug.
n
(pharmacology) A synthetic antiretroviral nucleoside drug C₁₀H₁₂N₂O₄ that is an analog of thymidine and a reverse transcriptase inhibitor, administered orally against HIV infection.
n
(pharmacology) An experimental antiviral drug, a prodrug of ribavirin.
n
(pharmacology) An antiviral drug with activity against orthopoxviruses such as smallpox.
n
(pharmacology) A protease inhibitor intended to treat hepatitis C.
n
(pharmacology) An antiviral drug used in the treatment of hepatitis B infection.
n
(pharmacology) A protease inhibitor.
n
An HIV inhibitor with the molecular formula C₂₄H₂₃N₇O₄.
n
(pharmacology) An antiretroviral drug of the protease inhibitor class that is used in to treat HIV infected patients.
n
(pharmacology) The salt form of the protease inhibitor drug tipranavir used in the treatment of HIV infected patients.
n
(pharmacology) A reverse transcriptase inhibitor.
n
(pharmacology) Abbreviation of tipranavir. [(pharmacology) An antiretroviral drug of the protease inhibitor class that is used in to treat HIV infected patients.]
n
(biochemistry) A peptide, isolated from a species of Treculia, that has anti-HIV properties
n
(medicine) targeted synthetic disease-modifying antirheumatic drug
n
A particular protease inhibitor used in the treatment of some leukemias
n
(pharmacology) An antiviral prodrug used in the management of herpes simplex and herpes zoster.
n
(pharmacology) A pyrimidine CCR5 entry inhibitor of HIV-1.
n
(pharmacology) A hepatitis C virus nonstructural protein 3/4A protease inhibitor.
n
(pharmacology) Abbreviation of zidovudine. [(pharmacology) A nucleoside analog reverse-transcriptase inhibitor C₁₀H₁₃N₅O₄, a type of antiretroviral drug that inhibits replication of some retroviruses (such as HIV) and was first approved for the treatment of AIDS.]
Note: Concept clusters like the one above are an experimental OneLook
feature. We've grouped words and phrases into thousands of clusters
based on a statistical analysis of how they are used in writing. Some
of the words and concepts may be vulgar or offensive. The names of the
clusters were written automatically and may not precisely describe
every word within the cluster; furthermore, the clusters may be
missing some entries that you'd normally associate with their
names. Click on a word to look it up on OneLook.
Our daily word games Threepeat and Compound Your Joy are going strong. Bookmark and enjoy!
Today's secret word is 7 letters and means "Property or assets, excluding real estate." Can you find it?